23 research outputs found

    What is the Source of Bilingual Cross-Language Activation in Deaf Bilinguals?

    Get PDF
    When deaf bilinguals are asked to make semantic similarity judgments of two written words, their responses are influenced by the sublexical relationship of the signed language translations of the target words. This study investigated whether the observed effects of ASL activation on English print depend on (a) an overlap in syllabic structure of the signed translations or (b) on initialization, an effect of contact between ASL and English that has resulted in a direct representation of English orthographic features in ASL sublexical form. Results demonstrate that neither of these conditions is required or enhances effects of cross-language activation. The experimental outcomes indicate that deaf bilinguals discover the optimal mapping between their two languages in a manner that is not constrained by privileged sublexical associations

    Industrial-Scale Decontamination Procedure Effects on the Content of Acaricides, Heavy Metals and Antioxidant Capacity of Beeswax

    Get PDF
    María Dolores Navarro-Hortal is a FPU fellow from the Spanish Ministry of Ciencia, Innovación y Universidades. We acknowledge Nutraceutical Translations for English language editing of this manuscript.Beeswax is useful for the beekeeping sector but also for the agro-food, pharmaceutical or cosmetics sectors. Frequently, this bee product is contaminated with pesticides reducing its utility and causing the decline in its market. This study aimed to prove the effectiveness of an industrial-scale decontamination method in removing acaricides from beeswax. Chlorfenvinphos and coumaphos decrease was higher than 90%, whereas tau fluvalinate decrease was only 30%. No changes were observed in the beeswax content of hydrocarbons and monoesters, whereas a decrease in the concentrations of Ca, Fe, Zn, Hg, Mn and P, and an increase in the concentrations of As and Si were found after the decontamination. Filtration reduced total phenolics, flavonoids and the antioxidant capacity of the lipophilic extract. These results demonstrate that the industrial method used was as effective as the method previously tested on a laboratory scale. The study also contributes to a better knowledge and characterization of beeswax, specially related to trace and ultra-trace elements and antioxidant capacity. Moreover, it offers the chance to further develop a method to effectively detect wax adulterations based on the chemical elements profile.The present study was partially funded by the “National Beekeeping Aid Program (Programa Nacional de Ayudas a la Apicultura)”, cofounded by the European Union and assigned to Spanish FEGA and FEAGA agencies (2016)

    Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

    Get PDF
    Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio

    La violencia contra la mujer en la pareja: Un estudio en el ámbito de la atención primaria Intimate partner violence: A survey conducted in the primary care setting

    No full text
    Objetivos: Determinar la prevalencia de violencia contra la mujer en la pareja en una muestra de mujeres asistentes por cualquier motivo a centros de atención primaria, y analizar las características de esta violencia. Métodos: Estudio transversal en 23 consultas de atención primaria de Andalucía, Madrid y Valencia. La muestra incluye 1.402 mujeres entre 18 y 65 años de edad elegidas aleatoriamente en estas consultas. Entre las variables recogidas mediante cuestionario autoadministrado se incluyeron la existencia de maltrato fisico, emocional o sexual, su temporalidad, su frecuencia y su duración. Resultados: El 32% del total de mujeres en la muestra tuvo algún tipo de maltrato a lo largo de su vida. El 7% presentó en algún momento de su vida maltrato físico y emocional a la vez, el 14% maltrato emocional, el 3% maltrato emocional y sexual conjuntamente y el 6% los 3 tipos de maltrato. El 52% de las mujeres que refirieron los 3 tipos de maltrato lo habían sufrido durante más de 5 años. Hay una mayor probabilidad de padecer maltrato en la actualidad habiéndolo sufrido con una pareja anterior en el pasado (odds ratio = 3,30; intervalo de confianza del 95%, 2,10-5,18). Conclusiones: Estos resultados ponen de manifiesto la magnitud de la violencia contra la mujer en la pareja en nuestro ámbito. Los profesionales de la salud se encuentran en una situación privilegiada para abordar este grave problema de salud pública.<br>Objectives: To determine the prevalence of intimate partner violence (IPV) in a sample of women attending primary care centers for any reason and to analyze the characteristics of this violence. Methods: A cross sectional study was performed in 23 primary care centers in three regions of Spain (Andalusia, Madrid and Valencia). The sample included 1,402 randomly selected adult women aged between 18 and 65 years attending these centers. Among the variables collected through a self-administered questionnaire were the existence of physical, emotional or sexual abuse, and its timing, duration, and frequency. Results: Overall, 32% had experienced some type of IPV. By type, 7% had experienced both physical and emotional IPV, 14% had experienced emotional IPV, 3% had experienced emotional and sexual IPV, and 6% had suffered all 3 types of IPV. Among the latter, 52% had experienced abuse for more than 5 years. Women who experienced abuse in a previous relationship had a greater probability of being abused by a new intimate partner (OR = 3.30; 95% CI, 2.10-5.18). Conclusions: These results show the scale of IPV in Spain. Health professionals play an important role in IPV, as they are in a privileged position to tackle this serious public health problem
    corecore